You are here

  • Home
  • Archive
  • Volume 82, Issue 1
  • EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases

Article metrics

Article menu

Download PDFPDF

Recommendation
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Free

 

Online download statistics by month:

Online download statistics by month: May 2022 to August 2024

AbstractFullPdf
May 202221862237842
Jun 202223432389682
Jul 202213201342370
Aug 202210291047316
Sep 202210661092344
Oct 2022922935317
Nov 2022537541181
Dec 2022312307133
Jan 2023776768327
Feb 2023334327195
Mar 2023339328167
Apr 2023230222142
May 2023275271137
Jun 2023276277141
Jul 2023223217111
Aug 202325324591
Sep 2023273276118
Oct 2023290264125
Nov 2023241242111
Dec 2023193182106
Jan 2024179176131
Feb 2024238226111
Mar 2024285269169
Apr 2024226219104
May 2024246235118
Jun 202418916893
Jul 202424722899
Aug 202418217491
Total15210152045872